A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of a chemotherapy regimen of intravenous
Herceptin, cisplatin and gemcitabine in patients with metastatic urothelial cancer. The
anticipated time on study treatment is until disease progression.